| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| 1 | 05-09-2024 | 03-31-2024 | 10-Q | |
| 2 | 03-01-2024 | 12-31-2023 | 10-K | |
| 3 | 11-03-2023 | 10-01-2023 | 10-Q | |
| 4 | 08-02-2023 | 07-02-2023 | 10-Q | |
| 5 | 06-02-2023 | 04-02-2023 | 10-Q |
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
On Sunday, Pfizer (NYSE: PFE) and AstraZeneca Plc (NASDAQ: AZN) were among the pharmaceutical companies who announced they will...
Kenvue Inc. (NYSE:KVUE) ("Kenvue") announced today the launch of a secondary underwritten public offering (the "Off...
-S-1
HSBC analyst Jeremy Fialko maintains Kenvue (NYSE:KVUE) with a Hold and raises the price target from $20 to $21.
Wall Street experienced a quiet session during morning trading on Tuesday, influenced by a lack of significant economic data an...
Kenvue's first-quarter sales of $3.89 billion. Organic growth surged by 1.9% amidst strong demand in Self Care and Essentia...
